A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

This study is ongoing, but not recruiting participants.

Study NCT00044135 Information provided by Triangle Pharmaceuticals

First Received: August 20, 2002 Last Updated: History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given